Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Apr. 30, 2024	Apr. 30, 2023
Cash flows from operating activities
Net loss	$ (71,799)	$ (79,388)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	7,445	7,053
Non-cash operating lease cost	941	1,090
Stock-based compensation	21,599	23,964
Amortization of deferred contract acquisition costs	785	675
Reserves and other	8,842	3,880
Changes in operating assets and liabilities:
Accounts receivable, net	4,783	(1,991)
Inventories	(24,977)	(53,136)
Prepaid expenses and other assets	(2,879)	(17,880)
Accounts payable, operating lease liabilities, and accrued and other liabilities	(10,792)	4,934
Deferred revenue	3,510	6,554
Net cash used in operating activities	(62,542)	(104,245)
Cash flows from investing activities
Purchases of property and equipment	(3,468)	(5,840)
Maturities of investments	0	105,000
Net cash provided by (used in) investing activities	(3,468)	99,160
Cash flows from financing activities
Proceeds from the issuance of common stock under employee equity plans, net of tax withholding	3,525	5,790
Proceeds from issuance of common stock in connection with ATM offerings, net of issuance costs	0	17,516
Change in driver funds and amounts due to customers	(2,483)	3,990
Settlement of contingent earnout liability	0	(3,537)
Net cash provided by financing activities	1,042	23,759
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(583)	511
Net increase (decrease) in cash, cash equivalents, and restricted cash	(65,551)	19,185
Cash, cash equivalents, and restricted cash at beginning of period	357,810	294,562
Cash, cash equivalents, and restricted cash at end of period	292,259	313,747
Supplementary cash flow information
Cash paid for interest	10,214	5,250
Cash paid for taxes	907	325
Supplementary cash flow information on noncash investing and financing activities
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities	1,659	1,824
Vesting of early exercised stock options	$ 0	$ 14